{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:02:36Z","timestamp":1790186556536,"version":"4.1.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate an alternative surgical approach for Port Delivery System with ranibizumab implant and a novel application of Iridex laser system in Gottingen minipig model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A total of 17 male minipigs (Part 1: nine animals in nonrecovery and Part 2: eight animals observed for 8 days after surgery Part 2) received Port Delivery System implant insertion into each eye. The effect of Iridex 810-nm infrared diode laser with varying energy (power or duration) on transscleral pars plana ablation surrounding ocular tissue and postsurgical vitreous hemorrhage was investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The most effective laser parameters for transscleral pars plana ablation in mitigating vitreous hemorrhage with no surrounding tissue damage were continuous wave mode, 1,750 mW, 1,000 ms, and 16 spots (eight overlapping spots\/sweep applied over two rows) across a 4 mm segment, posterior to the limbus, delivering a total energy of 28 J. Minimal self-limiting scleral hemorrhage was observed with two of the implants, and no vitreous hemorrhage was observed. Microcomputed tomography imaging was consistent with clinical ophthalmic observations. On microscopic observations, no tissue damage was observed at these laser settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This G\u00f6ttingen minipig model demonstrated a novel application of Iridex laser for transscleral pars plana ablation that streamlines the Port Delivery System implantation surgery.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004385","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T21:02:19Z","timestamp":1736370139000},"page":"996-1005","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["TRANSSCLERAL PARS PLANA CHOROID ABLATION USING THE IRIDEX LASER SYSTEM YIELDS IMPROVEMENTS FOR SURGICAL INSERTION OF THE PORT DELIVERY IMPLANT IN A MINIPIG MODEL"],"prefix":"10.1097","volume":"45","author":[{"given":"Amy","family":"Shelton","sequence":"first","affiliation":[{"name":"Department of Safety Assessment, Genentech, Inc, South San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Schutten","sequence":"additional","affiliation":[{"name":"Department of Pathology, Pfizer, Drug Safety Research and Development, Bothell, Washington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina N.","family":"Fuji","sequence":"additional","affiliation":[{"name":"Department of Safety Assessment, Genentech, Inc, South San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Boyd","sequence":"additional","affiliation":[{"name":"Department of Ocular Toxicology, Charles River Laboratories, Mattawan, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Department of Ocular Toxicology, Charles River Laboratories, Mattawan, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Leahy","sequence":"additional","affiliation":[{"name":"Department of Ocular Toxicology, Charles River Laboratories, Mattawan, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Knupp","sequence":"additional","affiliation":[{"name":"Zoetis, Kalamazoo, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juelline","family":"Lieng","sequence":"additional","affiliation":[{"name":"Department of Device Engineering, Genentech, Inc, South San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Device Engineering, Genentech, Inc, South San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Tam","sequence":"additional","affiliation":[{"name":"Department of Device Engineering, Genentech, Inc, South San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"LaMarche","sequence":"additional","affiliation":[{"name":"Department of Clinical and Medical Affairs, Iridex Corporation, Mountain View, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Barteselli","sequence":"additional","affiliation":[{"name":"Department of Late Stage Clinical Development, Ophthalmology, Genentech, Inc, South San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Late Stage Clinical Development, Ophthalmology, Genentech, Inc, South San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Bantseev","sequence":"additional","affiliation":[{"name":"Department of Safety Assessment, Genentech, Inc, South San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250422","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/10717544.2022.2069301","article-title":"The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery","volume":"29","author":"Ranade","year":"2022","journal-title":"Drug Deliv"},{"key":"R2-20250422","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ophtha.2019.03.036","article-title":"The Port Delivery System with ranibizumab for neovascular age-related macular degeneration","volume":"126","author":"Campochiaro","year":"2019","journal-title":"Ophthalmology"},{"key":"R3-20250422","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1097\/IAE.0000000000002614","article-title":"Evaluation of surgical factors affecting vitreous hemorrhage following port delivery system with ranibizumab implant insertion in a minipig model","volume":"40","author":"Bantseev","year":"2020","journal-title":"Retina"},{"key":"R4-20250422","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/0192623320968079","article-title":"Nonclinical toxicology and biocompatibility program supporting clinical development and registration of the port delivery system with ranibizumab for neovascular age-related macular degeneration","volume":"49","author":"Bantseev","year":"2021","journal-title":"Toxicol Pathol"},{"key":"R5-20250422","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3928\/23258160-20221121-01","article-title":"Five-year visual acuity outcomes of fovea-involving rhegmatogenous retinal detachments following pars plana vitrectomy (PPV) or combined PPV\/scleral buckle","volume":"53","author":"Awh","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R6-20250422","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3928\/23258160-20220408-01","article-title":"Implant insertion procedure of the port delivery system with ranibizumab: overview and clinical pearls","volume":"53","author":"Pieramici","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R9-20250422","first-page":"34","article-title":"Redefining cyclophotocoagulation with modified LASER delivery","volume":"12","author":"Radcliffe","year":"2016","journal-title":"Ophthalmology"},{"key":"R10-20250422","doi-asserted-by":"crossref","first-page":"107","DOI":"10.22336\/rjo.2017.20","article-title":"IRIDEX MicroPulse P3: innovative cyclophotocoagulation","volume":"61","author":"Gavris","year":"2017","journal-title":"Rom J Ophthalmol"},{"key":"R11-20250422","first-page":"2529","article-title":"Thickness and surface area","volume":"43","author":"Olsen","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T20:00:36Z","timestamp":1745352036000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004385","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}